TY - BOOK ID - 133833699 TI - Minimally Invasive Urological Procedures and Related Technological Developments PY - 2021 PB - Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute DB - UniCat KW - Medicine KW - Surgery KW - partial nephrectomy KW - single site surgery KW - sutureless KW - CEUS KW - contrast-enhanced ultrasound KW - renal ultrasound KW - image quality KW - small renal mass (3–5) KW - kidney stones KW - metabolic syndrome KW - urolithiasis KW - nephrolithiasis KW - kidney calculi KW - diabetes mellitus KW - acute kidney injury KW - percutaneous nephrolithotomy KW - urology KW - artificial intelligence KW - machine learning KW - urinary incontinence KW - kidney stone disease KW - fertility KW - reproductive urology KW - renal cell carcinoma KW - hydronephrosis KW - urinary reflux KW - endourology KW - pediatric urology KW - prostate cancer KW - bladder cancer KW - nephrostomy KW - quality of life KW - survival KW - decision making KW - ureteroscopy KW - laser KW - RIRS KW - Moses KW - holmium KW - mineral water KW - mineral composition KW - drinking water KW - still water KW - sparkling water KW - Ho:YAG laser KW - thulium fiber laser KW - laser fiber KW - lithotripsy KW - chronic prostatitis KW - chronic pelvic pain syndrome KW - extracorporeal shockwave therapy KW - ESWT KW - NIH-CPSI KW - EHS KW - IIEF-5 KW - QoL KW - urosepsis KW - laser lithotripsy KW - predictor factors KW - PCNL KW - renal tumour KW - AI KW - TFL UR - https://www.unicat.be/uniCat?func=search&query=sysid:133833699 AB - The landscape of minimally invasive urological intervention is changing. A lot of new innovations and technological developments have happened over the last 3 decades. Laparoscopy and robotic surgery have revolutionised kidney and prostate cancer treatment, with more minimally invasive procedures now being carried out than ever before. At the same time, technological advancements and the use of laser have changed the face of endourology. Several new innovative treatments are now commonplace for benign prostate enlargement (BPE). Management of prostate cancer now involves procedures such as robotic prostatectomy, brachytherapy, radiotherapy, cryotherapy and HIFU. Robotic partial nephrectomy and cryotherapy have changed the face of renal cancer. En-bloc resection of bladder cancer is challenging the traditional management of non-muscle invasive bladder cancer and becoming commonplace, while robotic cystectomy is also gaining popularity for muscle invasive bladder cancer. Newer surgical intervention related to BPE includes laser (holmium, thulium and green light), water-based treatment (Rezum, Aquablation) and other minimally invasive procedures such as prostate artery embolisation (PAE) and Urolift. Endourological procedures have incorporated newer laser types and settings such as moses technology, disposable ureteroscopes (URS) and minimisation of percutaneous nephrolithotomy (PCNL) instruments. All these technological innovations and improvements have led to shorter hospital stay, reduced cost, potential reduction in complications and improvement in the quality of life (QoL). ER -